Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing
Pleural effusion cfDNA NGS achieved an 88% mutation detection rate, outperforming cell pellet Sanger sequencing (78%) and clinical tissue testing (66%).”
Authors: Hsin-Yi Wang et al.